PMC3685360_01
Anatomic imaging with PET/CT; heterogeneous lesion in lower spleen pole
WO-17-20639-g001.jpg
PMC3685360_01_WO-17-20639-g001.jpg
F0001
Even though there was no significant growth in lesion size according to the imaging examinations that were performed every six months, because of the rise in activity values in F-18-fluorodeoxy-D-glucose PET/CT (Figs. 1, 2 and 3) a splenectomy was performed on the patient, in October 2011.
Fusion imaging with PET/CT; hyperactive lesion in spleen
WO-17-20639-g002.jpg
PMC3685360_01_WO-17-20639-g002.jpg
F0002
Even though there was no significant growth in lesion size according to the imaging examinations that were performed every six months, because of the rise in activity values in F-18-fluorodeoxy-D-glucose PET/CT (Figs. 1, 2 and 3) a splenectomy was performed on the patient, in October 2011.
3D splenic imaging with PET/CT; isolated hyperactive in - volvement in splenic area
WO-17-20639-g003.jpg
PMC3685360_01_WO-17-20639-g003.jpg
F0003
Even though there was no significant growth in lesion size according to the imaging examinations that were performed every six months, because of the rise in activity values in F-18-fluorodeoxy-D-glucose PET/CT (Figs. 1, 2 and 3) a splenectomy was performed on the patient, in October 2011.
Malignant melanoma metastasis to the spleen; histopathological examination by splenectomy; the characteristics of the tumor were observed to be oval-round cells creating solid islands and nest with mostly eosinophilic and pleomorphic nuclei (HE, magnification 20x). Additional immunohistochemical dyes were applied for this diagnosis
WO-17-20639-g004.jpg
PMC3685360_01_WO-17-20639-g004.jpg
F0004
As the splenectomy material was examined, it was assessed as melanoma metastasis (Fig. 4).